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Service organizational implementation trial
The U.S. juvenile justice system has a number of possible
behavioral health service community linkages for sub-
stance abuse and HIV services. However, there have only
been a small number of systemic studies that examine
and seek to improve these community behavioral health
linkages for involved youth. Implementation science, as
an emerging area, is a way of identifying, testing, and
understanding effective strategies for translating treat-
ment and prevention evidence-based approaches into
community behavioral health service delivery. The pur-
pose of this presentation, within the context of the Juve-
nile Justice-Translating Research Interventions for
Adolescents in the Legal System (JJ-TRIALS) implemen-
tation behavioral health trial, is to describe the diverse
settings in which the study will be initiated and how part-
ners are involved in the study design. State partners
include juvenile justice (JJ) and behavioral health services
organizations in seven states (Florida, Georgia, Kentucky,
Mississippi, New York, Pennsylvania, Texas) and the Dis-
trict of Columbia. Factors associated with selection, parti-
cipation, and implementing the study in 36 sites will be
explored. Each site will include a JJ agency and up to two
community behavioral health service organizations for
7–10 implementation team members representing execu-
tive, management, supervisory, and line staff. JJ partner
involvement is helping to design the study protocol that
is both feasible for sites and meets partner needs. Study
sites are defined as a county or service area, which can
include multiple counties when behavioral health services
are sparse. Site clusters will be used, which are defined
within each state to assure that each of the six research
centers have an equal number of experimental and
control sites to take into account broader contextual fac-
tors. Options for defining clusters include county size, JJ
youth population, urban/rural, or type of community
supervision — probation or juvenile drug court. Sites will
not be preselected for substance use or related behavioral
health service needs, so youth are included with diverse
behavioral health needs. Two JJ partners have actively
participated on the study design work group, and the
protocol has been vetted through partners at steering
committee meetings and conference calls.
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